Comparison of blood clot treatments illuminate recurrence risk in high-risk groups

Studies presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition compare new and standard-of-care treatments for blood clots and further illuminate clot risks in vulnerable populations, such as cancer patients. Source: Medical News Today Read More

Medical News Today